Stay updated on Ivacaftor Safety in Infants Clinical Trial
Sign up to get notified when there's something new on the Ivacaftor Safety in Infants Clinical Trial page.

Latest updates to the Ivacaftor Safety in Infants Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has removed detailed descriptions of a Phase 3 study on ivacaftor treatment for cystic fibrosis, including specific inclusion and exclusion criteria, while adding a reference to the EudraCT number and a new revision number.SummaryDifference21%
- Check29 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check87 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
- Check94 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
Stay in the know with updates to Ivacaftor Safety in Infants Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ivacaftor Safety in Infants Clinical Trial page.